Mrv0541 02231216142D 20 20 0 0 1 0 999 V2000 -1.6328 3.0647 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.9183 2.6522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9183 1.8272 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.6328 1.4147 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.3473 1.8272 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -3.0617 2.2397 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -2.7598 1.1127 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -1.9348 2.5416 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -0.2038 1.4147 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.2038 0.5897 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.5106 1.8272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5106 2.6522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.1568 3.1371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0981 3.9217 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.3868 4.5891 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.9231 3.9217 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.4080 4.5891 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.1781 3.1371 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.9627 2.8821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1342 2.0752 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 1 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 5 7 1 0 0 0 0 5 8 1 0 0 0 0 3 9 1 0 0 0 0 9 10 1 6 0 0 0 9 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 1 0 0 0 14 16 1 0 0 0 0 16 17 1 6 0 0 0 16 18 1 0 0 0 0 12 18 1 0 0 0 0 18 19 1 1 0 0 0 19 20 1 0 0 0 0 M CHG 3 6 -1 7 -1 8 -1 M END > DB02492 > drugbank > OC[C@H](OS([O-])([O-])[O-])[C@@H](O)CN1C[C@@H](O)[C@H](O)[C@H]1CO > InChI=1S/C9H21NO9S/c11-3-5-9(15)7(14)2-10(5)1-6(13)8(4-12)19-20(16,17)18/h5-9,11-18H,1-4H2/p-3/t5-,6+,7-,8+,9-/m1/s1 > InChIKey=YWOSRVQDYDWMAB-QKCLAQEOSA-K > 10 > 29.09498249009875 > 1 > 5 > 316.070226869 > -3 > C9H18NO9S > 0 > {[(2S,3S)-4-[(2R,3R,4R)-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-yl]-1,3-dihydroxybutan-2-yl]oxy}-$l^{4}-sulfanetris(olate) > -1.93 > -3.9381171156666666 > -0.61 > 316.306 > 0 > 1 > 1 > 13.744550653185431 > 13.141820922890307 > 6.979313607115662 > 182.79999999999998 > 62.99400000000001 > 7 > 1 > 8.94e+01 g/l > ghavamiol > 0 > DB02492 > experimental > Ghavamiol $$$$